echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: The era of vascular therapy is coming, and patients with posterior circulation ischemia may usher in new opportunities!

    Neurology: The era of vascular therapy is coming, and patients with posterior circulation ischemia may usher in new opportunities!

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Acute ischemic stroke, intracranial arterial vascular ischemic necrosis of the brain tissue of local stenosis or occlusion due to ischemia, hypoxia caused by high morbidity and mortality, especially after ischemic stroke cycle disease The disability rate and the mortality rate are as high as 80%, which seriously affects the quality of life of patients , and increases the medical and economic burdens of the family and society
    .

    The disability rate and fatality rate of stroke blood vessels, especially posterior circulation ischemic stroke, is as high as 80%, which seriously affects the quality of life of patients , and increases the medical and economic burdens of families and society
    .


    In particular, the disability rate and fatality rate of posterior circulation ischemic stroke are as high as 80%, which seriously affects the quality of life of patients , and increases the medical and economic burdens of the family and society


    At present, intravenous thrombolysis is the most effective ultra-early treatment method for acute ischemic stroke patients whose onset time is less than 6 hours


    Recently, experts from the Department of Radiology and Neurology at the University of Texas Southwestern Medical Center reviewed the clinical, imaging and anatomical features of posterior circulation ischemia (PCI), and dealt with basilar artery occlusion (BAO) Perform a systematic review of related results
    .


    The results were published in the journal Neurology


    Researchers review the literature to identify publications describing the risk factors, etiology, clinical manifestations, and imaging of PCI
    .


    Perform a systematic review based on the "Preferred Reporting Project for System Review and Meta-Analysis"


    manage

    The results show that PCI accounts for 15%-20% of strokes
    .


    In general, the risk factors are similar to anterior circulation stroke


    Dizziness (47%), unilateral limb weakness (41%), and dysarthria (31%) are the most common symptoms


    Recent trials have shown that endovascular treatment can make the recanalization rate of BAO reach more than 80%
    .


    Among the selected patients, 30%-60% of patients receiving endovascular treatment can obtain good curative effects, while patients who do not receive endovascular treatment


    Recent trials have shown that endovascular treatment can make the recanalization rate of BAO reach more than 80%


    It can be seen that PCI can manifest as fluctuating symptoms or clinical findings, which overlap with stroke-like cases and anterior circulation ischemia, making the diagnosis more dependent on imaging


    references:

    Posterior Circulation Ischemia in the Endovascular Era.


    Posterior Circulation Ischemia in the Endovascular Era.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.